The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
The computational tools will be designed to screen DNA sequences to detect biological threats that may arise from synthetic microbial manipulation.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
The Genome Project-Write researchers are meeting again, but ScienceInsider notes that the effort is lacking funds.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.